These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
18. A synthetic prostacyclin agonist with thromboxane synthase inhibitory activity, ONO-1301, protects myocardium from ischemia/reperfusion injury. Hirata Y; Shimabukuro M; Uematsu E; Soeki T; Yamada H; Sakai Y; Nakayama M; Matsumoto K; Igarashi T; Sata M Eur J Pharmacol; 2012 Jan; 674(2-3):352-8. PubMed ID: 22094066 [TBL] [Abstract][Full Text] [Related]
19. Thromboxane modulating agents. 3. 1H-imidazol-1-ylalkyl- and 3-pyridinylalkyl-substituted 3-[2-[(arylsulfonyl)amino]ethyl]benzenepropanoic acid derivatives as dual thromboxane synthase inhibitor/thromboxane receptor antagonists. Dickinson RP; Dack KN; Long CJ; Steele J J Med Chem; 1997 Oct; 40(21):3442-52. PubMed ID: 9341919 [TBL] [Abstract][Full Text] [Related]
20. Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase. Reilly IA; Doran JB; Smith B; FitzGerald GA Circulation; 1986 Jun; 73(6):1300-9. PubMed ID: 2938849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]